-
公开(公告)号:US20240065747A1
公开(公告)日:2024-02-29
申请号:US18468916
申请日:2023-09-18
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2018/00702 , A61B2018/0075 , A61B2018/00755 , A61B2018/00767 , A61B2018/00928
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US11672588B2
公开(公告)日:2023-06-13
申请号:US16874466
申请日:2020-05-14
申请人: GYRUS ACMI, INC.
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/0063 , A61B2018/0072 , A61B2018/0075 , A61B2018/00589 , A61B2018/00595 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00684 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00779 , A61B2018/00791 , A61B2018/00827 , A61B2018/00875 , A61B2018/00886 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1455 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US11666372B2
公开(公告)日:2023-06-06
申请号:US16874335
申请日:2020-05-14
申请人: GYRUS ACMI, INC
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/0063 , A61B2018/0072 , A61B2018/0075 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00779 , A61B2018/00791 , A61B2018/00827 , A61B2018/00875 , A61B2018/00886 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US20240315756A1
公开(公告)日:2024-09-26
申请号:US18734269
申请日:2024-06-05
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/00589 , A61B2018/00595 , A61B2018/0063 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00684 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/0072 , A61B2018/0075 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00779 , A61B2018/00791 , A61B2018/00827 , A61B2018/00875 , A61B2018/00886 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1455 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power-a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US11918274B2
公开(公告)日:2024-03-05
申请号:US16874071
申请日:2020-05-14
申请人: GYRUS ACMI, INC.
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/00589 , A61B2018/00595 , A61B2018/0063 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00684 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/0072 , A61B2018/0075 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00779 , A61B2018/00791 , A61B2018/00827 , A61B2018/00875 , A61B2018/00886 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1455 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US12059191B2
公开(公告)日:2024-08-13
申请号:US16874376
申请日:2020-05-14
申请人: GYRUS ACMI, Inc.
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/00589 , A61B2018/00595 , A61B2018/0063 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00684 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/0072 , A61B2018/0075 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00779 , A61B2018/00791 , A61B2018/00827 , A61B2018/00875 , A61B2018/00886 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1455 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US11883088B2
公开(公告)日:2024-01-30
申请号:US16874286
申请日:2020-05-14
申请人: GYRUS ACMI, INC.
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/0063 , A61B2018/0072 , A61B2018/0075 , A61B2018/00589 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00827 , A61B2018/00875 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US20240156509A1
公开(公告)日:2024-05-16
申请号:US18538054
申请日:2023-12-13
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2018/00702 , A61B2018/0075 , A61B2018/00755 , A61B2018/00767 , A61B2018/00928
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US11864813B2
公开(公告)日:2024-01-09
申请号:US16874042
申请日:2020-05-14
申请人: GYRUS ACMI, INC.
CPC分类号: A61B18/1206 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B18/1442 , A61B18/1445 , A61B2017/00017 , A61B2017/00115 , A61B2017/00132 , A61B2017/00154 , A61B2017/00194 , A61B2018/0063 , A61B2018/0072 , A61B2018/0075 , A61B2018/00589 , A61B2018/00595 , A61B2018/00642 , A61B2018/00648 , A61B2018/00654 , A61B2018/00666 , A61B2018/00678 , A61B2018/00684 , A61B2018/00702 , A61B2018/00708 , A61B2018/00714 , A61B2018/00755 , A61B2018/00761 , A61B2018/00767 , A61B2018/00779 , A61B2018/00791 , A61B2018/00827 , A61B2018/00875 , A61B2018/00886 , A61B2018/00898 , A61B2018/00928 , A61B2018/00994 , A61B2018/1455 , A61B2018/1467
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
公开(公告)号:US20240000495A1
公开(公告)日:2024-01-04
申请号:US18338594
申请日:2023-06-21
CPC分类号: A61B18/1206 , A61B18/1442 , A61B18/1445 , A61B18/00 , A61B18/1233 , A61B18/14 , A61B2018/00755 , A61B2018/00928 , A61B2018/00702 , A61B2018/00767 , A61B2018/0075 , A61B2017/00017
摘要: Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
-
-
-
-
-
-
-
-
-